Narrow search
Showing 1 - 10 of 126
Cover Image
An experimental test of loss aversion and scale compatibility
Bleichrodt, Han; Pinto, José Luis - Department of Economics and Business, Universitat … - 2000
This paper studies two important reasons why people violate procedure invariance, loss aversion and scale compatibility. The paper extends previous research on loss aversion and scale compatibility by studying loss aversion and scale compatibility simultaneously, by looking at a new decision...
Persistent link: https://www.econbiz.de/10005704839
Cover Image
An experimental test of loss aversion and scale compatibility
Bleichrodt, Han; Pinto, José Luis - Department of Economics and Business, Universitat … - 2000
This paper studies two important reasons why people violate procedure invariance, loss aversion and scale compatibility. The paper extends previous research on loss aversion and scale compatibility by studying loss aversion and scale compatibility simultaneously, by looking at a new decision...
Persistent link: https://www.econbiz.de/10005772150
Cover Image
Launching prices for new pharmaceuticals in heavily regulated and subsidized markets
Puig, Jaume; López-Valcárcel, Beatriz González - Department of Economics and Business, Universitat … - 2012
This paper provides empirical evidence on the explanatory factors affecting introductory prices of new pharmaceuticals in a heavily regulated and highly subsidized market. We collect a data set consisting of all new chemical entities launched in Spain between 1997 and 2005, and model launching...
Persistent link: https://www.econbiz.de/10010553343
Cover Image
Pharmaceutical generics, vertical product differentiation and public policy
Cabrales, Antonio - Department of Economics and Business, Universitat … - 2003
This paper studies oligopolistic competition in off-patent pharmaceutical markets using a vertical product differentiation model. This model can explain the observation that countries with stronger regulations have smaller generic market shares. It can also explain the differences in observed...
Persistent link: https://www.econbiz.de/10005827428
Cover Image
Pharmaceutical generics, vertical product differentiation and public policy
Cabrales, Antonio - Department of Economics and Business, Universitat … - 2003
This paper studies oligopolistic competition in off-patent pharmaceutical markets using a vertical product differentiation model. This model can explain the observation that countries with stronger regulations have smaller generic market shares. It can also explain the differences in observed...
Persistent link: https://www.econbiz.de/10005772420
Cover Image
The determinants of pricing in pharmaceuticals: Are U.S. prices really higher than those of Canada?
Cabrales, Antonio; Jiménez-Martín, Sergi - Department of Economics and Business, Universitat … - 2007
This paper studies price determination in pharmaceutical markets using data for 25 countries, six years and a comprehensive list of products from the MIDAS IMS database. We show that market power and the quality of the product has a significantly positive impact of prices. The nationality of the...
Persistent link: https://www.econbiz.de/10005772557
Cover Image
Who is afraid of the big bad ban? An evaluation of the effects of the Spanish clean air law on expenditure at hospitality venues
Villar, Jaume Garcia; López-Nicolás, Ángel - Department of Economics and Business, Universitat … - 2014
Background: In January 2011 Spain modified clean air legislation in force since 2006, removing all existing exceptions applicable to hospitality venues. Although this legal reform was backed by all political parties with parliamentary representation, the government’s initiative was contested...
Persistent link: https://www.econbiz.de/10010891945
Cover Image
Health investment complementarities under competing risks
Dow, William H.; Philipson, Tomas; Sala-i-Martin, Xavier; … - Department of Economics and Business, Universitat … - 1997
immediate, but will make health investments so as to equalize cause--specific mortality. However, equal mortality risk from a … variety of diseases does not imply that disease--specific public health interventions are a waste. Rather, a cause … is also altered as a result of intervention. Analyzing data from one of the most important public health programs ever …
Persistent link: https://www.econbiz.de/10005772551
Cover Image
The impact of eliminating a child benefit on birth timing and infant health
Borra, Cristina; Luna, Libertad González; … - Department of Economics and Business, Universitat … - 2013
We study the effects of the cancellation of a sizeable child benefit in Spain on birth timing and neonatal health. In … announcement effects are important, and that families and health professionals may face effective trade-offs when deciding on the …
Persistent link: https://www.econbiz.de/10010849600
Cover Image
World population growth and fertility patterns, 1960-2000. A simple model explaining the evolution of world's fertility during the second half of the 20th Century
Camps, Enriqueta; Engerman, Stanley - Department of Economics and Business, Universitat … - 2008
In this paper we attempt to describe the general reasons behind the world population explosion in the 20th century. The size of the population at the end of the century in question, deemed excessive by some, was a consequence of a dramatic improvement in life expectancies, attributable, in turn,...
Persistent link: https://www.econbiz.de/10004961445